Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347545 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347538 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347585 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347577 (4-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347578 (4-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347571 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347518 (3-Chloro-5-{[3-(4-chloro-2-methylphenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347579 (4-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347585 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347591 (5-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347547 (2-(Azetidin-1-yl)-4-{[3-(4-chloro-2-methylphenyl)p...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347599 (5-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347575 (4-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347612 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-[(1-methy...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347576 (4-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347521 (3-Chloro-5-{[3-(4-methoxy-2-methylphenyl)piperidin...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347590 (5-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347607 (3-(4-Chloro-2-methylphenyl)-1-[(1-ethyl-1H-pyrazol...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347584 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347596 (5-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347541 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-N-m...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347594 (5-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347610 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347595 (5-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347613 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-[(1-ethyl...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347598 (5-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347609 (3-(4-Chloro-2-methylphenyl)-1-[(1-methyl-1H-pyrazo...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347608 (3-(4-Chloro-2-methylphenyl)-1-{[1-(propan-2-yl)-1H...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347532 (4-{[(3R)-3-(4-Chlorophenyl)piperidin-1-yl]carbonyl...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347516 (4-{[3-(2,4-Dichlorophenyl)piperidin-1-yl]carbonyl}...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347528 (N,N-Dimethyl-4-{[3-(2-methylphenyl)piperidin-1-yl]...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347602 (3-(4-Chloro-2-methylphenyl)-1-[(1,3-dimethyl-1H-py...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347597 (5-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347559 (N,N-Dimethyl-4-({3-[2-(trifluoromethyl)phenyl]pipe...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347568 (N-Methyl-4-({3-[2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347530 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-N,N...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347620 (4-{[5-(4-Chloro-2-methylphenyl)-1,2,3,4-tetrahydro...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347520 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347525 (3-Chloro-5-{[3-(2-methoxyphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347525 (3-Chloro-5-{[3-(2-methoxyphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347614 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-{[1-(prop...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347615 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347569 (4-{[3-(4-Methoxyphenyl)piperidin-1-yl]carbonyl}-N-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347589 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347562 (4-{[3-(2-Methoxyphenyl)piperidin-1-yl]carbonyl}-N,...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347525 (3-Chloro-5-{[3-(2-methoxyphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 420 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347619 (4-{[5-(4-Chlorophenyl)-1,2,3,4-tetrahydropyridin-1...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 420 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347626 (4-{[3-(4-Chlorophenyl)azepan-1-yl]carbonyl}-N-meth...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347570 (4-{[3-(2-Methoxyphenyl)piperidin-1-yl]carbonyl}-N-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347625 (4-{[3-(4-Methoxyphenyl)azepan-1-yl]carbonyl}-N-met...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347519 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347561 (4-{[3-(4-Methoxyphenyl)piperidin-1-yl]carbonyl}-N,...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347540 (4-{[3-(2-Chloro-4-fluorophenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347546 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347618 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-[(1,3-dim...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347566 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-2-e...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347539 (4-{[3-(4-Chloro-2-fluorophenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347615 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347605 (3-(4-Chlorophenyl)-1-[(1-ethyl-1H-pyrazol-4-yl)car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347580 (4-({3-[2-(Difluoromethoxy)phenyl]piperidin-1-yl}ca...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347592 (3-(Azetidin-1-yl)-5-({3-[4-chloro-2-(trifluorometh...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 730 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347583 (5-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-N,N...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 810 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347572 (2-Ethyl-4-({3-[2-(trifluoromethyl)phenyl]piperidin...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 820 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347544 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-2-(...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347531 (4-{[(3S)-3-(4-Chlorophenyl)piperidin-1-yl]carbonyl...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 840 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347628 (5-{[3-(4-Chlorophenyl)azepan-1-yl]carbonyl}-N-meth...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 930 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347537 (2-(Azetidin-1-yl)-4-{[3-(2-methylphenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347606 (3-(4-Chlorophenyl)-1-{[1-(propan-2-yl)-1H-pyrazol-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347624 (4-{[3-(4-Methoxyphenyl)azepan-1-yl]carbonyl}-N,N-d...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347525 (3-Chloro-5-{[3-(2-methoxyphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 990 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347616 (1-[(1,3-Dimethyl-1H-pyrazol-4-yl)carbonyl]-3-(4-me...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347536 (2-(Azetidin-1-yl)-4-{[3-(4-chlorophenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347600 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347529 (N,N-Dimethyl-4-[(3-phenylpiperidin-1-yl)carbonyl]p...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347524 (3-Chloro-4-{[3-(4-chloro-2-methylphenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347587 (5-{[(3S)-3-(4-Chloro-2-methylphenyl)piperidin-1-yl...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347535 (2-(Azetidin-1-yl)-4-{[3-(4-methylphenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347534 (2-Ethyl-4-{[3-(4-methylphenyl)piperidin-1-yl]carbo...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347533 (4-{[3-(4-Fluorophenyl)piperidin-1-yl]carbonyl}-N,N...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347621 (4-{[5-(2,4-Dichlorophenyl)-1,2,3,4-tetrahydropyrid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347601 (5-{[3-(2-Methoxyphenyl)piperidin-1-yl]carbonyl}-N-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347627 (5-{[3-(4-Methoxyphenyl)azepan-1-yl]carbonyl}-N-met...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347604 (3-(4-Chlorophenyl)-1-[(1-methyl-1H-pyrazol-4-yl)ca...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347542 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-2,6...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347631 (3-(4-Chloro-2-methylphenyl)-1-{[2-(dimethylamino)p...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347523 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347629 (5-{[3-(4-Methoxyphenyl)azepan-1-yl]carbonyl}-N,N-d...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347630 (5-{[3-(4-Chlorophenyl)azepan-1-yl]carbonyl}-N,N-di...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347617 (4-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347582 (4-{[3-(4-Chloro-2,6-dimethylphenyl)piperidin-1-yl]...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347573 (2-Ethyl-4-{[3-(2-methoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347574 (N,N-Dimethyl-4-({3-[2-(trifluoromethoxy)phenyl]pip...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347517 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-2-c...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347603 (3-(4-Chlorophenyl)-1-[(1,3-dimethyl-1H-pyrazol-4-y...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347515 (4-{[3-(2-Fluorophenyl)piperidin-1-yl]carbonyl}-N,N...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347527 (N,N-Dimethyl-4-{[3-(3-methylphenyl)piperidin-1-yl]...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347581 (2-(1-{[2-(Dimethylamino)pyridin-4-yl]carbonyl}pipe...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347611 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-[(1H-pyra...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347526 (2-Methyl-4-{[3-(4-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347567 (N-Methyl-4-({3-[4-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347622 (N,N-Dimethyl-4-[(3-phenylazepan-1-yl)carbonyl]pyri...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.97E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347593 (5-({3-[2-Methoxy-4-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347623 (4-{[3-(4-Chlorophenyl)azepan-1-yl]carbonyl}-N,N-di...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347522 (3-Chloro-5-({3-[4-methoxy-2-(trifluoromethyl)pheny...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347543 (2-Chloro-4-{[3-(4-chlorophenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347632 (1-{[2-(Dimethylamino)pyridin-4-yl]carbonyl}-3-(4-f...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347558 (N,N-Dimethyl-4-({3-[4-(trifluoromethyl)phenyl]pipe...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347548 (2-Methoxy-4-{[3-(4-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347550 (4-{[(3S)-3-(3-Methoxyphenyl)piperidin-1-yl]carbony...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347551 (N-Ethyl-N-methyl-4-{[3-(4-methylphenyl)piperidin-1...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.53E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347552 (2-(3,3-Difluoroazetidin-1-yl)-4-{[3-(4-methylpheny...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347554 (N-Methyl-4-{[3-(4-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347557 (N-Cyclopropyl-N-methyl-4-{[3-(4-methylphenyl)piper...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347560 (4-{[3-(2-Chlorophenyl)piperidin-1-yl]carbonyl}-N,N...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.79E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347553 (N-Methyl-4-{[3-(4-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347556 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-2-e...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347555 (1-(4-{[3-(4-Methylphenyl)piperidin-1-yl]carbonyl}p...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347549 (4-{[3-(4-Methylphenyl)piperidin-1-yl]carbonyl}-2-(...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347615 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair |